Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer. (Q55070432)
Jump to navigation
Jump to search
scientific article published on 27 October 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer. |
scientific article published on 27 October 2014 |
Statements
Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer. (English)
1 reference
Laurie E Gaspar
1 reference
Puneeth Iyengar
1 reference
Brian D Kavanagh
1 reference
Zabi Wardak
1 reference
Irma Smith
1 reference
Chul Ahn
1 reference
Jonathan Dowell
1 reference
Randall Hughes
1 reference
Ramzi Abdulrahman
1 reference
D Ross Camidge
1 reference
Robert C Doebele
1 reference
Paul A Bunn
1 reference
Hak Choy
1 reference
Robert Timmerman
1 reference
27 October 2014
1 reference
32
1 reference
34
1 reference
3824-3830
1 reference